Stability of Tranexamic Acid Mouth Rinse
Download in electronic PDF format for $75
Abstract: Tranexamic acid is an antifibrinolytic agent that inhibits the conversion of plasminogen to plasmin and is used to treat fibrinolytic hemorrhages. Tranexamic acid mouth rinse was compounded using active pharmaceutical ingredient powder or commercial tablets. The bitter taste was masked by using either cherry-vanilla or peppermint and mint flavoring and aspartame. Tranexamic acid mouth rinse solutions were stored at either 23°C or 5°C in polyethylene terephthalate bottles for 31 days. Stability was accessed using a stability-indicating high-performance liquid chromatographic method. Color, clarity, caking, resuspendability, and pH were also monitored. All solutions remained above 97.2% of the initial concentrations after 31 days storage at either 23°C or 5°C and protected from light. The powder-based solutions remained clear, and no color change was observed. However, some of the tablet formulations stored at 23°C turned yellow to dark brown after 21 days. Insoluble material from the tablet formulations settled out but was easy to resuspend with no caking. The pH of the tranexamic acid mouth rinse solutions changed slightly over the course of the study. All tranexamic acid mouth rinse solutions were chemically stable for 31 days when stored at either 23°C or 5°C and protected from light.
Related Keywords:
tranexamic acid, formulations, antifibrinolutic agent, plasminogen, plasmin, fibrinolysis, fibrinolytic hemorrhage, oral bleeding, dental procedures, shelf life, mouth rinse, flavoring, chemical stability
Related Categories:
FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, DOSAGE FORMS/DRUG CARRIERS, HEMOSTASIS, BLEEDING, ANTICOAGULATION
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Tranexamic Acid Mouth Rinse
Donnelly Ronald F
|
Sep/Oct 2018
Pg. 412-416
|
Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 48-50
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 147
|
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing
Song Guiyun, Banov Daniel, Bassani August S
|
Jan/Feb 2018
Pg. 60-65
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 417
|
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 71
|
Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 302
|
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers
McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
|
Sep/Oct 2014
Pg. 432-437
|
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 148
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping, Trissel Lawrence A
|
Mar/Apr 1997
Pg. 132-134
|
Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
de Villiers Melgardt M, Narsai Kirti, van der Watt Jakkie G
|
Jan/Feb 2000
Pg. 72-75
|
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
|
Nov/Dec 2019
Pg. 504-510
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth
Bassani August S, Keim David
|
Nov/Dec 2004
Pg. 436-440
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L, Bogner Robin H
|
May/Jun 2009
Pg. 214-217
|
Return to Top |